Detalhe da pesquisa
1.
How I prevent viral reactivation in high-risk patients.
Blood
; 141(17): 2062-2074, 2023 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36493341
2.
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
J Infect Dis
; 229(2): 413-421, 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37506264
3.
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
Clin Infect Dis
; 78(3): 562-572, 2024 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38036487
4.
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.
Clin Infect Dis
; 78(3): 775-784, 2024 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37815489
5.
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovir.
Transpl Infect Dis
; 25 Suppl 1: e14171, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37864299
6.
Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell-Depleted Hematopoietic Cell Transplant.
J Infect Dis
; 225(3): 453-464, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34390240
7.
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
Clin Infect Dis
; 75(5): 795-804, 2022 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34979021
8.
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
Clin Infect Dis
; 75(4): 690-701, 2022 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34864943
9.
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
Blood
; 135(17): 1447-1451, 2020 04 23.
Artigo
Inglês
| MEDLINE | ID: mdl-32076716
10.
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.
Cytotherapy
; 24(4): 428-436, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35042670
11.
Atypical pathogens presenting with pulmonary consolidations detected by cell-free DNA next-generation sequencing in patients with hematologic malignancies.
Infect Dis Clin Pract (Baltim Md)
; 30(2)2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35586753
12.
Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant.
J Infect Dis
; 224(4): 620-631, 2021 08 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33864371
13.
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33782007
14.
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study.
J Antimicrob Chemother
; 76(11): 3020-3028, 2021 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34324678
15.
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
Med Mycol
; 59(10): 970-979, 2021 Oct 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34036319
16.
Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.
J Infect Dis
; 222(7): 1180-1187, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32374872
17.
Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(10): 1937-1947, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32640313
18.
Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study.
Biol Blood Marrow Transplant
; 26(8): 1482-1491, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32315708
19.
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.
Biol Blood Marrow Transplant
; 26(11): 1983-1994, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32736007
20.
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1195-1202, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32088367